Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease (nejm.org) 1 points by mathoff 9y ago ↗ HN
[–] mathoff 9y ago ↗ "RESULTS At 48 weeks, the least-squares mean percentage reduction in LDL cholesterol levels with evolocumab, as compared with placebo, was 59% [...]"
1 comment
[ 3.5 ms ] story [ 6.7 ms ] thread